Desk›Healthcare› Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd
BSE 524412 · NSE AAREYDRUGS · ISIN INE198H01019 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹84.92
+5.00%
BSE close, 28 August 2026
₹240.78 cr
2.8 cr shares · Micro cap
₹146.75 cr
as published
49.4× · 1.78×
EPS ₹1.72 · BV ₹47.71
472.27 / 3.97
₹ cr, as filed
19
2 selected · 11%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -15.1% |
|---|---|
| Against 52-week low | +68.5% |
| Day change | +5.00% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹1.72 |
|---|---|
| Price / earnings | 49.37× |
| Price / book | 1.78× |
| Book value — derived, price ÷ P/B | ₹47.71 |
| Return on equity | 3.60% |
| Operating margin | 6.81% |
| Net margin | 2.29% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 3.61%
- ROE as published
- 3.60%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 44.63 | 1.02 | 0.36 | 6.81% | 2.29% |
| Mar-26 · Q | 189.47 | 1.56 | 0.55 | 2.06% | 0.82% |
| FY25-26 | 472.27 | 3.97 | 1.39 | 2.81% | 0.84% |
Quarter on quarter
- Revenue, quarter on quarter
- -76.4%
- Net profit, quarter on quarter
- -34.6%
- Operating margin, quarter on quarter
- +475 bps
Disclosure profile 19 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| AGM / EGM | 3 |
| General | 2 |
| Newspaper Publication | 2 |
| Outcome | 2 |
| SAST | 2 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Book Closure | 1 |
| Compliance Certificate | 1 |
| Other Update | 1 |
| Trading Window | 1 |
| Procedural sub-total | 17 |
| Total | 19 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
19 filings · 2 selected · busiest 2026-09-08 and 2026-09-30
Filing rhythm · the twelve most recent
2026-09-082026-10-08
SelectedProcedural
Filings
19 in the window · 2 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate Under Reg 74(5) of SEBI(DP) Regulation 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
7 October 2026 ·
Board Meeting Outcome for Revised Outcome
Revised outcome
Company Update / Revision of outcome View filing →
-
5 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizers Report of 36th Annual General Meeting
AGM/EGM / AGM View filing →
-
5 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nimit Rajesh Ghatalia
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
5 October 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nimit Rajesh Ghatalia
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
AGM Proceedings of 36th Annual General Meeting
AGM/EGM / AGM View filing →
-
30 September 2026 ·
Revised Outcome Of Board Meeting Dated 06-08-2026 Approved In Board Meeting 30-09-2026
Revised Outcome of Board Meeting dated 06-08-2026 approved in Board Meeting 30-09-2026
Company Update / General View filing →
-
30 September 2026 ·
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 30-09-2026
OUTCOME OF BOARD MEETING HELD ON 30-09-2026
Others / Outcome without intimation View filing →
-
23 September 2026 ·
Closure of Trading Window
Intimation for Closure of trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
11 September 2026 ·
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015
Disclosure Under Regulation 30of SEBI(Listing Obligation And Disclosure Requirement ) Regulation, 2015
Company Update / General View filing →
-
9 September 2026 ·
-
8 September 2026 ·
Reg. 34 (1) Annual Report.
Notice and Integrated Annual Report for 36TH Annual General Meeting of Company as required under Regulation 34(1)
Others / Reg. 34 (1) Annual Report View filing →
-
8 September 2026 ·
Notice Of 36Th Annual General Meeting Of The Company For FY 2025-26
Notice of 36th Annual General Meeting of the Company for the FY 2025-26
AGM/EGM / AGM View filing →
-
8 September 2026 ·
-
17 August 2026 ·
-
14 August 2026 ·
Unaudited Financial Results For The Quarter Ended 30Th June, 2026
As per Attachment
Result / Financial Results View filing →
-
14 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 14Th August, 2026
Outcome of Board Meeting held on friday, 14th August, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
7 August 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting
Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve This is to intimate ....
Board Meeting / Board Meeting View filing →
-
6 August 2026 ·
Board Meeting Outcome for Allotment Of Equity Shares Pursuant To Conversion Of Warrants
Allotment of Equity Shares Pursuant to Conversion of Warrants
Others / Outcome without intimation View filing →
RSS feed for Aarey Drugs & Pharmaceuticals Ltd · the 50 most recent filings